• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number E105 - KIT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cellulitis (1768); Hematoma (1884); Unspecified Infection (1930)
Event Date 04/15/2016
Event Type  Injury  
Manufacturer Narrative
System was used for treatment.Kit lot e105 was reviewed.There were no non-conformances related to the complaint.This lot met all release requirements.Uvadex lot # ad8348 was reviewed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint categories cellulitis and infection (infected hematoma) and no trend was detected for either of these categories.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.Although there was no device malfunction, the patient condition deteriorated post treatment and it is possible the device/treatment was a contributing factor, hence this event has been assessed as reportable.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.(b)(4).
 
Event Description
Customer reported a (b)(6) female patient with a history of acute graft vs.Host disease of the gut and skin completed 2 days of extracorporeal photopheresis (ecp) on (b)(6) 2016.This was completed without any complications noted.On april 15, they report she developed vasculitis.They report she had and infected hematoma and was an immunosuppressed patient.She was admitted for further treatment.Hematoma evacuated - about 600ml on (b)(6).No permanent damage to a body structure was reported.On follow up the site reported she has recurrence of disease, and she has relapsed relatively early post transplant.Medical is establishing the best treatment for her in terms of treating disease and limiting side effects.She is also treated for the recurrent left leg cellulitis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS
hampton NJ 08827
Manufacturer (Section G)
THERAKOS
hampton NJ 08827
Manufacturer Contact
megan vernak
53 frontage road
hampton, NJ 08827
MDR Report Key5849141
MDR Text Key51222232
Report Number2523595-2016-00170
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Nurse
Type of Report Initial
Report Date 07/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Nurse
Device Expiration Date01/01/2018
Device Lot NumberE105 - KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/06/2016
Initial Date FDA Received08/04/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age38 YR
Patient Weight72
-
-